CD23

CD23 Overview

English NameImmunoglobulin epsilon Fc receptorApproved Drugs0
Drugs in Clinical Trials2Target SynonymLow affinity immunoglobulin epsilon Fc receptor,FCE2,CD23A,FCER2,CLEC4J,BLAST-2,Fc Fragment Of IgE Receptor II,C-Type Lectin Domain Family 4, Member J,Immunoglobulin Epsilon-Chain,CD23,Lymphocyte IgE Receptor,Fc Epsilon Receptor II,Fc-Epsilon-RII,CD23 Antigen,IGEBF,Fc Fragment Of IgE, Low Affinity II, Receptor For (CD23A),C-Type Lectin Domain Family 4 Member J,Immunoglobulin E-binding factor,Fc Fragment Of IgE, Low Affinity II, Receptor For (CD23)
Highest Development StagePhase 2 Clinical
English NameImmunoglobulin epsilon Fc receptor
Target SynonymLow affinity immunoglobulin epsilon Fc receptor,FCE2,CD23A,FCER2,CLEC4J,BLAST-2,Fc Fragment Of IgE Receptor II,C-Type Lectin Domain Family 4, Member J,Immunoglobulin Epsilon-Chain,CD23,Lymphocyte IgE Receptor,Fc Epsilon Receptor II,Fc-Epsilon-RII,CD23 Antigen,IGEBF,Fc Fragment Of IgE, Low Affinity II, Receptor For (CD23A),C-Type Lectin Domain Family 4 Member J,Immunoglobulin E-binding factor,Fc Fragment Of IgE, Low Affinity II, Receptor For (CD23)
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 2 Clinical

CD23 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (2)Mouse (1)

  • Tag

    His Tag & Avi Tag (1)His Tag (2)

  • Conjugate

    Biotin-labeled (1)Unconjugated (2)

CD23 Background

Cluster of differentiation 23 (CD23) is also known as Low affinity immunoglobulin epsilon Fc receptor (FCER2), C-type lectin domain family 4 member J (CLEC4J), Fc-epsilon-RII (FcεRII), Immunoglobulin E-binding factor (IGEBF), is the 'low-affinity' receptor for IgE, an antibody isotype involved in allergy and resistance to parasites, and is important in regulation of IgE levels. Unlike many of the antibody receptors, CD23 is a C-type lectin. It is found on mature B cells, activated macrophages, eosinophils, follicular dendritic cells, and platelets.

CD23 Synonyms

FCER2,CD23,CD23A,CLEC4J,FCE2,IGEBF,FcεRII,FcεRⅡ

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
UB-221UB-221Phase 2 ClinicalChinese Academy Of SciencesChronic Urticaria
Details
RO-7297089RO-7297089; AFM-26; RG-6296Phase 1 ClinicalGenentech IncMultiple Myeloma
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland